SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000905718-19-000096
Filing Date
2019-02-01
Accepted
2019-02-01 16:01:43
Documents
1
Period of Report
2019-01-31

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3156
  Complete submission text file 0000905718-19-000096.txt   4627
Mailing Address 201 ROUTE 17 NORTH 2ND FLOOR RUTHERFORD NJ 07070
Business Address 201 ROUTE 17 NORTH 2ND FLOOR RUTHERFORD NJ 07070 201.528.9200
CANCER GENETICS, INC (Issuer) CIK: 0001349929 (see all company filings)

IRS No.: 043462475 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8071 Services-Medical Laboratories
Assistant Director 9

Mailing Address C/O CANCER GENETICS INC. 201 ROUTE 17 NORTH, 2ND FLOOR RUTHERFORD NJ 07070
Business Address
Miles Michael Glenn (Reporting) CIK: 0001760938 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35817 | Film No.: 19559857